uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
AdCD40L Immunstimulatory Gene Therapy in Combination with Cyclophosphamide Prolongs 6-Months Survival in a Phase I/II Trial for Malignant Melanoma.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology. (Gustav J. Ullenhag)
2014 (English)Conference paper, Poster (with or without abstract) (Other academic)
Place, publisher, year, edition, pages
2014.
National Category
Cancer and Oncology
Research subject
Oncology
Identifiers
URN: urn:nbn:se:uu:diva-403373OAI: oai:DiVA.org:uu-403373DiVA, id: diva2:1388776
Conference
Association for Cancer Immunotherapy (CIMT) congress, 6-8 May 2014, Mainz
Available from: 2020-01-27 Created: 2020-01-27 Last updated: 2020-01-27

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Maleka, Aglaia
By organisation
Department of Immunology, Genetics and Pathology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 1 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf